Position history for Wealthspire Advisors, LLC's holdings in Catalyst Pharmaceuticals Inc
Wealthspire Advisors, LLC holds 34,359 shares of CPRX (Catalyst Pharmaceuticals Inc), worth $850,729 as of 2026-Q1. The position was decreased (-7.5% shares). CPRX represents 0.0% of Wealthspire Advisors, LLC's portfolio.
Current Value
$850,729
Current Shares
34,359
Total Value Change
+$288,565
Total Shares Change
-1,933
Other major holders of CPRX: BlackRock, Inc.
Decreased |
| 34,359 |
-7.5% |
| $850,729 |
| 0.0% |
| $23.92 |
0 |
| 2025-Q4 | Increased | 37,160 | +0.9% | $867,315 | 0.0% | $23.29 | 25 |
| 2025-Q3 | Decreased | 36,843 | -0.1% | $725,807 | 0.0% | $19.55 | 0 |
| 2025-Q2 | Increased | 36,879 | +7.1% | $800,275 | 0.0% | $21.78 | 27 |
| 2025-Q1 | Increased | 34,434 | +0.2% | $835,025 | 0.0% | $24.69 | 25 |
| 2024-Q4 | Increased | 34,355 | +0.3% | $716,989 | 0.0% | $21.07 | 25 |
| 2024-Q3 | Decreased | 34,271 | -5.6% | $681,308 | 0.0% | $19.56 | 0 |
| 2024-Q2 | Unchanged | 36,292 | 0.0% | $562,164 | 0.0% | $15.49 | 0 |